Diseases, Conditions, Syndromes

FDA warns about treating COVID-19 with unproven drugs

(HealthDay)—Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S. Food and Drug Administration warned Americans on Friday.


FDA warns of heart risks with Trump-promoted malaria drug

The U.S. Food and Drug Administration on Friday warned doctors against prescribing a malaria drug touted by President Donald Trump for treating the new coronavirus except in hospitals and research studies.


Startling these twins could put their hearts at risk

Katie and Lance Cox were watching TV one evening, their infant twins Carter and John asleep nearby, when Katie dropped the remote control. As it clattered across the floor, the couple froze, staring terrified at one another.


Hydroquinidine cuts serious arrhythmic events in SQTS

(HealthDay)—Treatment with hydroquinidine (HQ) prolongs the QT interval in patients with short QT syndrome (SQTS) and reduces the occurrence of life-threatening arrhythmic events (LAE), according to a study published in ...

Diseases, Conditions, Syndromes

Zelboraf approved for use in Erdheim-Chester disease

(HealthDay)—Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration as the first drug to treat certain adults patients with Erdheim-Chester disease (ECD).

page 1 from 3